Tweenvest Stocks

co.don AG (DB: CNW)

Health Care · Biotechnology · DE

0.01

+3.85% today · 0.0% 1Y

co.don AG (DB: CNW) operates in the Biotechnology industry within the Health Care sector. The company is valued at $420.57K and employs 134 people.

Over the last twelve months the share price has gained 0.0%, trading between 0.00 and 0.04.

Tweenvest scores co.don AG across four factors: quality 34/100, value 39/100. Its strongest factor is value.

CNW price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$420.57K
Revenue (TTM)
P/E
EPS
-0.01
Dividend yield
Beta (5Y)
2.07
52-week high
€0.04
52-week low
€0.00
Avg volume (3M)
Shares outstanding
26.72M
Employees
134
Next earnings

About co.don AG

co.don AG, a biopharmaceutical company, develops, produces, and markets cell-based pharmaceutical products for joint preservation and the regenerative treatment of articular cartilage defects worldwide. It offers Spherox, a three dimensional chondrocyte product that is used to treat cartilage defects in adult knee joints; and co.don chondrosphere for the treatment of cartilage defects in the hip, ankle, shoulder and elbow, and knees of younger patients. The company serves accident and orthopedic surgeons. co.don AG was founded in 1993 and is headquartered in Teltow, Germany.

ISIN
DE000A3E5C08
Founded
1993
Listed since
Feb 14, 2001
Exchange
Deutsche Boerse AG
Currency
EUR
CompanyMarket capPriceDay
AbbVie Inc.NYSE: ABBV$469.68B$265.79+0.48%
Amgen Inc.NasdaqGS: AMGN$239.09B$442.24-0.36%
Gilead Sciences, Inc.NasdaqGS: GILD$184.47B$148.77+1.38%
Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX$140.13B$552.85+0.96%
Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN$83.24B$833.56+0.61%
argenx SEENXTBR: ARGX$64.17B879.20+1.74%
Moderna, Inc.NasdaqGS: MRNA$63.41B$158.83+14.36%
CSL LimitedASX: CSL$59.49BAU$173.64+2.68%

Browse every Biotechnology company →

Figures last refreshed Aug 18, 2026.